Jason S. Troutt
Jason S. Troutt publishes mostly in Surgery, Molecular Biology and Endocrinology, Diabetes and Metabolism, on topics such as Lipoproteins and Cardiovascular Health, Cholesterol and Lipid Metabolism and Diabetes, Cardiovascular Risks, and Lipoproteins.
- World rank
- #817,499 of 7,710,434 ranked researchers
- Rank in United States
- #272,253 of 1,627,098
- Works
- 27
- Citations
- 2k
- Citations per work
- 72.3
What does Jason S. Troutt research?
Jason S. Troutt's work is mostly in Medicine (55%), Biochemistry, Genetics and Molecular Biology (11%), Immunology and Microbiology (6%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences1554.9%
- Medicine1554.9%
- Everything else828.2%
- Life Sciences516.9%
- 1Surgery32% of their works
- 2Molecular Biology11% of their works
- 3Endocrinology, Diabetes and Metabolism10% of their works
- 4Hematology7% of their works
- 5Immunology6% of their works
- 6Epidemiology6% of their works
Research topics
- Lipoproteins and Cardiovascular Health
- Cholesterol and Lipid Metabolism
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Protease and Inhibitor Mechanisms
- Iron Metabolism and Disorders
- Peroxisome Proliferator-Activated Receptors
- Protein Kinase Regulation and GTPase Signaling
- Atherosclerosis and Cardiovascular Diseases
Which keywords describe Jason S. Troutt's research?
The keywords of their largest research topics: Cholesterol-lowering, Statins, Atherosclerosis, Cholesterol, Metabolism, Inflammation, Diabetes and LXR.
- Protein Kinases
- PPARs
- Immune Response
- Matrix Metalloproteinases
- Hepcidin
- Metabolic Syndrome
- SREBP
- LXR
- Inflammation
- Cholesterol
- Statins
- Cholesterol-lowering
- Atherosclerosis
- Metabolism
- Diabetes
- Obesity
- Cardiovascular Disease
- Transcriptional Regulation
- Iron Regulation
- Tissue Inhibitors of Metalloproteinases
- Oxidized LDL
- Peroxisome Proliferator-Activated Receptors
- Ras Signaling
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 23 words, with their numbers
- Cholesterol-lowering161 topic
- Statins161 topic
- Atherosclerosis123 topics
- Cholesterol102 topics
- Metabolism82 topics
- Inflammation73 topics
- Diabetes62 topics
- LXR61 topic
- Obesity62 topics
- SREBP61 topic
- Cardiovascular Disease41 topic
- Metabolic Syndrome41 topic
- Transcriptional Regulation42 topics
- Hepcidin31 topic
- Iron Regulation31 topic
- Matrix Metalloproteinases31 topic
- Tissue Inhibitors of Metalloproteinases31 topic
- Immune Response21 topic
- Oxidized LDL21 topic
- PPARs21 topic
- Peroxisome Proliferator-Activated Receptors21 topic
- Protein Kinases21 topic
- Ras Signaling21 topic
Where does Jason S. Troutt work?
Jason S. Troutt's main affiliation in the publication record is Eli Lilly (United States), United States.
How many publications and citations does Jason S. Troutt have?
OpenAlex counts 27 works and 1,953 citations for Jason S. Troutt, an h-index of 18, ranking #817,499 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Jason S. Troutt. Posts are plain text and can be reported.